Drugs / ARC19499
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01191372 | Sep 2010 → Dec 2011 | hemophilia | Baxalta now part of Shire | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARC19499 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01191372 ↗ |
| Known as | BAX-499 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297890 ↗ |
| Action | Inhibit | “Anti-tissue factor pathway inhibitor (TFPI) aptamer” NCT01191372 ↗ |
| Modality | Aptamer | “Anti-tissue factor pathway inhibitor (TFPI) aptamer” NCT01191372 ↗ |